Eye Centre

Medicine & Life Sciences

1. Glaucoma 100%
2. Eye 86%
3. Finland 68%
4. Retinal Pigment Epithelium 62%
5. Population 55%
6. Eye Diseases 52%
7. Ocular Vision 52%
8. Vision Disorders 46%
9. Visual Field Tests 44%
10. Quality of Life 40%
11. tear proteins 39%
12. Body Mass Index 38%
13. Health 36%
14. Pinus sylvestris 35%
15. Proteomics 35%
16. Macular Degeneration 33%
17. Epithelial Cells 32%
18. dorzolamide-timolol combination 32%
19. Pathologic Neovascularization 31%
20. Retinal Diseases 30%
21. trabecular meshwork-induced glucocorticoid response protein 29%
22. Glaucoma Drainage Implants 29%
23. Syndecan-4 28%
24. Human Embryonic Stem Cells 28%
25. Diabetic Retinopathy 28%
26. Multifocal Intraocular Lenses 27%
27. Visual Acuity 27%
28. Pseudoxanthoma Elasticum 27%
29. Incidence 27%
30. angiotensin I (1-7) 26%
31. Oxygen 25%
32. Intraocular Pressure 25%
33. Ophthalmology 24%
34. Dry Eye Syndromes 24%
35. cadherin 5 24%
36. Elderly 24%
37. Cataract 24%
38. Carbonic Anhydrases 24%
39. Proteins 23%
40. Demography 23%
41. Laser In Situ Keratomileusis 22%
42. Amblyopia 22%
43. Hyperoxia 22%
44. Automation 22%
45. Vascular Malformations 22%
46. Intraocular Lens Implantation 21%
47. Tumor Necrosis Factor Inhibitors 21%
48. Retina 21%
49. Tears 21%
50. Aqueous Humor 21%
51. Sodium Channels 21%
52. Mental Health 21%
53. Pluripotent Stem Cells 21%
54. Stem Cells 21%
55. Facial Paralysis 20%
56. Induced Pluripotent Stem Cells 20%
57. Thinness 20%
58. Registries 20%
59. Phagocytosis 19%
60. Facial Nerve 19%
61. Calcium Channels 19%
62. Erectile Dysfunction 19%
63. Immune System Diseases 19%
64. Renin-Angiotensin System 18%
65. Hematopoietic Stem Cells 17%
66. Treatment Failure 17%
67. Vascular Endothelial Growth Factor A 17%
68. Lenses 17%
69. Uncertainty 16%
70. Fungi 16%
71. Life Style 16%
72. Obesity 15%
73. Morbid Obesity 15%
74. Cost-Benefit Analysis 15%
75. Mass Spectrometry 15%
76. Blood Pressure 15%
77. brinzolamide 15%
78. Cohort Studies 15%
79. Rodentia 14%
80. Mitochondria 14%
81. Cell Differentiation 14%
82. Hypertension 14%
83. Peptides 14%
84. Prospective Studies 14%
85. Therapeutics 14%
86. Timolol 14%
87. Epithelium 13%
88. Exfoliation Syndrome 13%
89. Learning 13%
90. Blood Vessels 12%
91. Breast Neoplasms 11%
92. Serum 10%
93. Hypoxia 10%
94. Transplantation 10%
95. Ecosystem 9%
96. Exudates and Transudates 9%
97. Visual Fields 9%
98. Benchmarking 9%
99. Genes 9%
100. Income 9%